Deficiency of Flcn in mouse kidney were reported to promote kidney cell proliferation (21), kidney cyst, hyperplasia, and kidney tumors (3, 21–25) through activation of mTORC and AMPK signaling pathways (26, 27). Here, FLCN is linked to kidney neoplasm.